The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Akzo Nobel N.V. (AKZA; AKZOY) publishes results for Q4 and full-year 2024 Highlights Q4 2024 (compared with Q4 2023) - Organic sales up 1% on price/mix; revenue up 4% - Adjusted EBITDA up ...
PRNewswire/ -- "For the full year 2024, net sales amounted to SEK 526.8 billion (552.3) and the adjusted operating income to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback